ID   PELP1_RAT               Reviewed;        1130 AA.
AC   Q56B11; Q3MIE2;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2005, sequence version 2.
DT   02-OCT-2024, entry version 114.
DE   RecName: Full=Proline-, glutamic acid- and leucine-rich protein 1;
DE   AltName: Full=Modulator of non-genomic activity of estrogen receptor;
GN   Name=Pelp1; Synonyms=Mnar;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hypothalamus;
RX   PubMed=16141397; DOI=10.1210/en.2005-0276;
RA   Khan M.M., Hadman M., Wakade C., De Sevilla L.M., Dhandapani K.M.,
RA   Mahesh V.B., Vadlamudi R.K., Brann D.W.;
RT   "Cloning, expression, and localization of MNAR/PELP1 in rodent brain:
RT   colocalization in estrogen receptor-alpha- but not in gonadotropin-
RT   releasing hormone-positive neurons.";
RL   Endocrinology 146:5215-5227(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Coactivator of estrogen receptor-mediated transcription and a
CC       corepressor of other nuclear hormone receptors and sequence-specific
CC       transcription factors. Plays a role in estrogen receptor (ER) genomic
CC       activity when present in the nuclear compartment by activating the ER
CC       target genes in a hormonal stimulation dependent manner. Can facilitate
CC       ER non-genomic signaling via SRC and PI3K interaction in the cytosol.
CC       Plays a role in E2-mediated cell cycle progression by interacting with
CC       RB1. May have important functional implications in ER/growth factor
CC       cross-talk. Interacts with several growth factor signaling components
CC       including EGFR and HRS. Functions as the key stabilizing component of
CC       the Five Friends of Methylated CHTOP (5FMC) complex; the 5FMC complex
CC       is recruited to ZNF148 by methylated CHTOP, leading to desumoylation of
CC       ZNF148 and subsequent transactivation of ZNF148 target genes. Component
CC       of the PELP1 complex involved in the nucleolar steps of 28S rRNA
CC       maturation and the subsequent nucleoplasmic transit of the pre-60S
CC       ribosomal subunit. Regulates pre-60S association of the critical
CC       remodeling factor MDN1. {ECO:0000250|UniProtKB:Q8IZL8}.
CC   -!- SUBUNIT: Interacts with HRS, RXRA, SUMO2, HDAC2, RB1 and STAT3.
CC       Interacts with PI3K, SRC and EGFR in cytoplasm. Interacts with ESR1,
CC       the interaction is enhanced by 17-beta-estradiol; the interaction
CC       increases ESR1 transcriptional activity (By similarity). Interacts with
CC       CREBBP and EP300 in a ligand-dependent manner (By similarity). Forms
CC       two complexes in the presence of 17-beta-estradiol; one with SRC and
CC       ESR1 and another with LCK and ESR1. Interacts with histone H1 and H3
CC       with a greater affinity for H1. Component of some MLL1/MLL complex, at
CC       least composed of the core components KMT2A/MLL1, ASH2L, HCFC1/HCF1,
CC       WDR5 and RBBP5, as well as the facultative components BAP18, CHD8,
CC       E2F6, HSP70, INO80C, KANSL1, LAS1L, MAX, MCRS1, MGA, KAT8/MOF, PELP1,
CC       PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B, SENP3, TAF1, TAF4,
CC       TAF6, TAF7, TAF9 and TEX10. Core component of the 5FMC complex, at
CC       least composed of PELP1, LAS1L, TEX10, WDR18 and SENP3; the complex
CC       interacts with methylated CHTOP and ZNF148. Interacts with NOL9.
CC       Interacts with BCAS3. Component of the PELP1 complex, composed of at
CC       least PELP1, TEX10 and WDR18. The complex interacts (via PELP1) with
CC       MDN1 (via its hexameric AAA ATPase ring) and the pre-60S ribosome
CC       particles. {ECO:0000250|UniProtKB:Q8IZL8}.
CC   -!- SUBCELLULAR LOCATION: Nucleus, nucleolus
CC       {ECO:0000250|UniProtKB:Q8IZL8}. Nucleus, nucleoplasm
CC       {ECO:0000250|UniProtKB:Q8IZL8}. Nucleus {ECO:0000269|PubMed:16141397}.
CC       Cytoplasm {ECO:0000269|PubMed:16141397}. Note=Mainly found in the
CC       nucleoplasm, with low levels detected in the cytoplasm. Also found
CC       associated with the plasma membrane. {ECO:0000250|UniProtKB:Q8IZL8}.
CC   -!- TISSUE SPECIFICITY: Expressed in ovary, uterus, muscle and many regions
CC       of brain including hypothalamus, cortex, hippocampus and pituitary.
CC       Expressed in neurin and glia cells. {ECO:0000269|PubMed:16141397}.
CC   -!- DOMAIN: The Glu-rich region mediates histones interaction.
CC       {ECO:0000250|UniProtKB:Q8IZL8}.
CC   -!- DOMAIN: The Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs are required for the
CC       association with nuclear receptor ESR1. {ECO:0000250|UniProtKB:Q8IZL8}.
CC   -!- PTM: Transiently sumoylated, preferentially conjugated to SUMO2 or
CC       SUMO3. Sumoylation causes nucleolar exclusion of PELP1 and promotes the
CC       recruitment of MDN1 to pre-60S particles. Desumoylation by SUMO
CC       isopeptidase SENP3 is needed to release both PELP1 and MDN1 from pre-
CC       ribosomes. {ECO:0000250|UniProtKB:Q8IZL8}.
CC   -!- SIMILARITY: Belongs to the RIX1/PELP1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY970831; AAX81519.2; -; mRNA.
DR   EMBL; BC101890; AAI01891.1; -; mRNA.
DR   RefSeq; NP_001019441.2; NM_001024270.2.
DR   AlphaFoldDB; Q56B11; -.
DR   SMR; Q56B11; -.
DR   BioGRID; 262017; 1.
DR   IntAct; Q56B11; 3.
DR   MINT; Q56B11; -.
DR   STRING; 10116.ENSRNOP00000026102; -.
DR   iPTMnet; Q56B11; -.
DR   PhosphoSitePlus; Q56B11; -.
DR   jPOST; Q56B11; -.
DR   PaxDb; 10116-ENSRNOP00000026102; -.
DR   GeneID; 360552; -.
DR   KEGG; rno:360552; -.
DR   UCSC; RGD:1306320; rat.
DR   AGR; RGD:1306320; -.
DR   CTD; 27043; -.
DR   RGD; 1306320; Pelp1.
DR   eggNOG; ENOG502QQE7; Eukaryota.
DR   InParanoid; Q56B11; -.
DR   OrthoDB; 3090187at2759; -.
DR   PhylomeDB; Q56B11; -.
DR   TreeFam; TF331332; -.
DR   Reactome; R-RNO-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   PRO; PR:Q56B11; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0000791; C:euchromatin; ISS:UniProtKB.
DR   GO; GO:0071339; C:MLL1 complex; ISS:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0032183; F:SUMO binding; ISO:RGD.
DR   GO; GO:0071391; P:cellular response to estrogen stimulus; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0006364; P:rRNA processing; IBA:GO_Central.
DR   Gene3D; 1.25.10.10; Leucine-rich Repeat Variant; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR012980; PELP1_middle.
DR   InterPro; IPR012583; RIX1_N.
DR   PANTHER; PTHR34105; PROLINE-, GLUTAMIC ACID- AND LEUCINE-RICH PROTEIN 1; 1.
DR   PANTHER; PTHR34105:SF1; PROLINE-, GLUTAMIC ACID- AND LEUCINE-RICH PROTEIN 1; 1.
DR   Pfam; PF08166; PELP1_HEAT; 2.
DR   Pfam; PF08167; RIX1; 1.
DR   PRINTS; PR01217; PRICHEXTENSN.
DR   SUPFAM; SSF48371; ARM repeat; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Cytoplasm; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Repressor; Transcription; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IZL8"
FT   CHAIN           2..1130
FT                   /note="Proline-, glutamic acid- and leucine-rich protein 1"
FT                   /id="PRO_0000252138"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2..80
FT                   /note="Required for modulation of ESR1 transcriptional
FT                   activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IZL8"
FT   REGION          121..189
FT                   /note="Required for modulation of ESR1 transcriptional
FT                   activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IZL8"
FT   REGION          639..773
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          785..1130
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           33..37
FT                   /note="LXXLL motif 1"
FT   MOTIF           69..73
FT                   /note="LXXLL motif 2"
FT   MOTIF           111..115
FT                   /note="LXXLL motif 3"
FT   MOTIF           155..159
FT                   /note="LXXLL motif 4"
FT   MOTIF           177..181
FT                   /note="LXXLL motif 5"
FT   MOTIF           264..268
FT                   /note="LXXLL motif 6"
FT   MOTIF           271..275
FT                   /note="LXXLL motif 7"
FT   MOTIF           365..369
FT                   /note="LXXLL motif 8"
FT   MOTIF           460..464
FT                   /note="LXXLL motif 9"
FT   MOTIF           580..584
FT                   /note="LXXLL motif 10"
FT   MOTIF           585..589
FT                   /note="LXXLL motif 11"
FT   COMPBIAS        640..660
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        674..688
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        691..705
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        806..833
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        844..874
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        892..971
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        978..997
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1114..1130
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IZL8"
FT   MOD_RES         13
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBD5"
FT   MOD_RES         478
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IZL8"
FT   MOD_RES         482
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IZL8"
FT   MOD_RES         757
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IZL8"
FT   MOD_RES         761
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9DBD5"
FT   MOD_RES         1034
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IZL8"
FT   MOD_RES         1044
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8IZL8"
FT   CONFLICT        190
FT                   /note="Q -> E (in Ref. 2; AAI01891)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        519
FT                   /note="D -> N (in Ref. 2; AAI01891)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        824
FT                   /note="I -> T (in Ref. 2; AAI01891)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        913
FT                   /note="V -> E (in Ref. 2; AAI01891)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1130 AA;  119139 MW;  A5216F56C80D0BE8 CRC64;
     MAAAVLSGPT TGSPAGAPGG PGGLSAAGSG PRLRLLLLES VSGLLQPRTG SHVAPVHPPI
     QWAPYLPGLM CLLRLHGTAG GAQNLSALGA LVNLSNAHLS SIKTRFEGLC LLSLLVGESP
     TELFQQHCVS WLRSIQQVLQ SQDSPPTMEL AVAILRDLLR YASQLPTLFR DISTNHLPGL
     LTSLLGLRPQ CEQSALEGMK ACVTYFPRAC GFLKGKLASF FLSRLDSLNP QLQQLACECY
     SRLPSLGAGF SQGLKHTENW EQELHSLLTS LHSLLGSLFE ETETAPVQSE GPGVEMLLSP
     SEDDNTHVLL QLWQRFSGLA RCLGLMLSSE FGAPVSVPVQ EILDLICRIL GISSKNINLL
     GDGPLRLLLL PSLHLEALDL LSALILACGG RLLRFGALIS RLLPQVLNTW STGRDALAPG
     QERPYSTIRT KVYAILELWV QVCGASAGML QGGASGEALL THLLSDISPP ADALKLCSTR
     GSSDGGLQSG KPSAPKKLKL DMGEALAPPS QRKGDRNADS DVCAAALRGL SRTILMCGPL
     VKEETHRRLH DLVLPLVMSV QQGEVLGSSP YNSSCCRLEL YRLLLALLLA PSPRCPPPLS
     CALKAFSLGQ WEDSLEVSSF CSEALVTCSA LTHPRVPPLQ SSGPACPTPA PVPPPEAPSS
     FRAPAFHTPG PMPSIGALPS PGPVPSAGPI PTVGSMSSAG SVPSTGPVPS RPGPPATANH
     LGLAVPGLVS VPPRLLPGSE NHRAGSGEDP VLAPSGTPPP SIPPDETFGG RVPRPAFVHY
     DKEEASDVEI SLESDSDDSV VIVPEGLPSL PPPPSGTPPP VAPIGPPTAS PPVPAKEDSE
     ELPATPGPLP PPPPPPPPVS GPVTLPPPQL VPEGTPGGGG PTAMEEDLTV ININSSDEEE
     EEEEEEEEED EDVEEEDFEE EEEDEEEYFE EEEEEEEFEE EFEEEEGELE EEEEEEEEEL
     EEVEDVEFGS AGEVEEGGPP PPTLPPALPP TDSPKVQPEA EPEPGLLLEV EEPGAEDGPG
     PEIAPTLAPE VLPSQEEVER EGESPTAGPP QELVEEESSA PPTLLEEGTE GGGDKVPPPP
     ETPAQEEMET ETEASAPQGK EQDDTAAMLA DFIDCPPDDE KPPPATEPDS
//
